Model-informed drug development to support nemolizumab clinical development in adults and adolescents with moderate to severe atopic dermatitis Publication Model-informed drug development to support nemolizumab clinical development in adults and adolescents with moderate to severe atopic dermatitis This article describes how a model-informed drug development (MIDD) approach was used to support the…CertaraMarch 24, 2026
Regulatory horizons 2026: Clinical pharmacology strategy and regulatory expectations Blog Regulatory horizons 2026: Clinical pharmacology strategy and regulatory expectations Learn how regulatory expectations in clinical pharmacology are evolving and how to build a strategy…CertaraMarch 24, 2026
From Numbers to Narrative: Mastering the Art of PK Presentation Guide From Numbers to Narrative: Mastering the Art of PK Presentation Master PK data reporting with a structured guide to presenting pharmacokinetic results clearly and turning…CertaraMarch 20, 2026
Pharmacometrics Under Pressure On-Demand Webinar Pharmacometrics Under Pressure popPK modelers and pharmacometricians, ensure your toolset can handle use cases from translation to population.CertaraMarch 20, 2026
What are common bioequivalence study mistakes? Blog What are common bioequivalence study mistakes? Learn about the most common bioequivalence study mistakes drug developers make and the differences between…CertaraMarch 20, 2026
Pediatric Drug Development and Pharmacometrics: Key Questions Sponsors Must Answer Guide Pediatric Drug Development and Pharmacometrics: Key Questions Sponsors Must Answer Download Certara’s expert guide on pharmacometrics and pediatric drug development. Learn how modeling, MIDD, and…CertaraMarch 19, 2026
Advancing pharmacoequity through model-informed drug development: Insights from ASCPT 2026 Blog Advancing pharmacoequity through model-informed drug development: Insights from ASCPT 2026 Explore how model-informed drug development and AI are advancing pharmacoequity and shaping the future of…CertaraMarch 11, 2026
Modeling Platinum-Induced Nephrotoxicity: A PK/TD Analysis of Calbindin and B2-Microglobulin Urinary Biomarkers Webinar Modeling Platinum-Induced Nephrotoxicity: A PK/TD Analysis of Calbindin and B2-Microglobulin Urinary Biomarkers CertaraMarch 9, 2026
Navigate GxP Compliance in the Cloud with Confidence Guide Navigate GxP Compliance in the Cloud with Confidence Master SaaS GxP compliance with risk-based computer system validation (CSV) aligned to GAMP 5, FDA,…CertaraMarch 6, 2026